Bristol-Myers Squibb Receives FDA Approval for Opdivo nivolumab in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma, a Type of Bladder Cancer. By a News Reporter-Staff News Editor at Biotech Business Week Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration has approved Opdivo injection, for intraveno
Human Growth Hormone hGH Market: Innovation in Drug Delivery System with Eli Lilly and Company, Novartis AG, Novo Nordisk& Pfizer Dominating- Research and Markets. By a News Reporter-Staff News Editor at Pharma Business Week Research and Markets has announced the addition of the "Global Human Growth Hormone Market: Industry Analysis& Outlook" rep
New Findings from Hongik University in the Area of Chemical Engineering Reported. Our news editors obtained a quote from the research from Hongik University, "Sodium hyaluronate and carboxymethyl cellulose were chosen as structural materials and amylopectin was used to increase the mechanical strength of microneedles. For more information on this..
By a News Reporter-Staff News Editor at Diabetes Week A patent by the inventor Jacobson, Sven Martin, filed on October 8, 2015, was published online on February 7, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9561176 is assigned to Remedy Pharmaceuticals, Inc.. The following quot
By a News Reporter-Staff News Editor at Clinical Trials Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventor Joshi, Laxminarayan, filed on February 3, 2015, was published online on February 7, 2017. The patent's assignee for patent number 9561187 is CMAX Technologies, Inc.. "TOPROL-XL.RTM. is an extended-releas
By a News Reporter-Staff News Editor at Nanotechnology Weekly Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting out of Milan, Italy, by VerticalNews editors, research stated, "The synthesis of nanogels as devices capable to maintain the drug level within a desired range for a long and sust
Study Results from I. Simpson and Colleagues Broaden Understanding of Drug Research. By a News Reporter-Staff News Editor at Pharma Business Week New research on Drug Research is the subject of a report. GSK gained USA approval for its shingles vaccine, but Novo Nordisk and Sanofi received complete response letters from the US FDA, requiring furt
Feb. 20 Teva Pharmaceutical Industries Ltd.' s Copaxone war is over. It would be a mistake, however, to think that Copaxone is the only arrow in Teva's bow. The company produces 120 billion tablets a year, and its sales totaled $22 billion in 2016.
ETF Daily News puts it best: Biotechnology is now showing the first signs of life. Indeed, the US Patent Office put an end to the CRISPR-Cas9 patent dispute last week, declaring, no interference in fact. This was welcome news for Editas Medicine, whose co-founder was part of the patent dispute. Zosano Pharma Peregrine Pharmaceuticals Be
SASKATOON, Saskatchewan& STONEY CREEK, Ontario Today, CanniMed Therapeutics Inc. and CTT Pharmaceutical Holdings Inc. have entered into a definitive contractual relationship for the licensing of CTT s Orally Dissolvable Thin Film Wafer technology. This industry-first collaboration includes the licensing of six patents related to cannabinoid
Findings from South Central University for Nationalities in Drug Delivery Systems Provides New Insights. According to news reporting from Hubei, People's Republic of China, by NewsRx journalists, research stated, "A tumor targeting redox-responsive drug delivery system with bioactive surface was constructed by immobilizing peptide-based amphiphile.
We are presently conducting an open label, Phase II clinical trial of proposed therapy for Gorlin Syndrome, and in August 2016 and October 2016, we announced positive interim data from this trial. We have exclusive rights in the U.S. to develop and to commercialize SUBA-Itraconazole Capsules for the treatment of human cancer via oral administration
According to news reporting originating in Patras, Greece, by NewsRx journalists, research stated, "The development of anticancer drug delivery systems which retain or enhance the cytotoxic properties of the drug to tumorous tissues, while reducing toxicity to other organs is of key importance. Funders for this research include European Union, Nati
17 February 2017, 07:00 GMT. AstraZeneca today announced positive results from its Phase III OLYMPIAD trial comparing Lynparza tablets to physician's choice of a standard of care chemotherapy in the treatment of patients with HER2-negative metastatic breast cancer harbouring germline BRCA1 or BRCA2 mutations. Sean Bohen, Executive Vice President,..
AstraZeneca today announced positive results from its Phase III OlympiAD trial comparing LYNPARZA? tablets to physician s choice of a standard of care chemotherapy in the treatment of patients with HER2-negative metastatic breast cancer harboring germline BRCA1 or BRCA2 mutations. 1 Patients treated with LYNPARZA showed a statistically-signifi
New Drug Delivery Systems Data Have Been Reported by Investigators at National Institute for Materials Science. According to news reporting originating from Ibaraki, Japan, by NewsRx correspondents, research stated, "A novel drug delivery platform, mesoporous phospholipid particle, is introduced. Our news editors obtained a quote from the research
New Drug Delivery Systems Findings Reported from University of Sao Paulo. Our news journalists obtained a quote from the research from the University of Sao Paulo, "Fluorescent nanoparticles were prepared by a Quality-by-Design modified nanoprecipitation technique. Our news journalists report that additional information may be obtained by contactin
New Drug Delivery Systems Study Findings Recently Were Reported by Researchers at University of Illinois. Funders for this research include National Science Foundation, National Institutes of Health. Our news journalists obtained a quote from the research from the University of Illinois, "This tendency causes a gradual loss of concentration when a
According to news reporting from Andhra Pradesh, India, by NewsRx journalists, research stated, "Drug delivery through liposomes offers several advantages, but still challenging to the researchers for the use of liposomes as carriers in drug delivery due to their poor physical stability, unpredictable drug encapsulation and systemic availability of
New Findings from Hong Kong Polytechnic University in the Area of Drug Delivery Systems Described. The news correspondents report that additional information may be obtained from W.F. Lai, Hong Kong Polytechnic University, Dept. of Appl Biol& Chem Technol, Hong Kong, Hong Kong, People's Republic of China. Keywords for this news article include: Hon
One Day Workshop: Human Factors and Usability Engineering in the Development of Drug Delivery Products- London, United Kingdom- April 5, 2017- Research and Markets. By a News Reporter-Staff News Editor at Drug Week Research and Markets has announced the addition of the "Human Factors and Usability Engineering in the Development of Drug Delivery P
By a News Reporter-Staff News Editor at Drug Week INTEC PHARMA LTD. has been issued patent number 9554991, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Navon, Nadav; Moor, Eytan; Kirmayer, David; Kluev, Elena; Carni, Giora. This patent was filed on January 14, 2016 and was publ
Perrigo Company plc today announced it has received final approval from the U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution, 5 mg/1. 5 mg per 5 mL. Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, offers patients and customers high quality p
Recent Findings from A.M. Dyer and Co-Researchers Yields New Information on Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. According to news reporting originating from Nottingham, United Kingdom, by NewsRx correspondents, research st